| Typicality: | 0.270 |
| Saliency: | 0.251 |
| very | 6 | degree |
| in early testing | 6 | temporal |
| in 96% of adults ages | 2 | other |
| vaccine → produce → strong immune response | 6 |
| vaccine → elicit → strong immune response | 6 |
| vaccine → stimulate → strong immune response | 4 |
| vaccine → induce → strong responses | 3 |
| negative | neutral | positive |
| 0.018 | 0.295 | 0.687 |
| Raw frequency | 19 |
| Normalized frequency | 0.251 |
| Modifier score | 0.500 |
| Perplexity | 45.092 |